Transmitted HIV-1 drug resistance in Estonian residents and Ukrainian refugees in 2020 and 2022
Identifying HIV DRMs using HIVdb Program combined with CPR tools gives comprehensive overview of transmitted drug resistance. Resistance testing might be necessary before initiating antiretroviral therapy if the first-line treatment does not include PI or second-generation IN strand transfer inhibitors.
Authors
- Irja Lutsar (ORCID: https://orcid.org/0000-0002-5082-429X)
- Hiie Soeorg (ORCID: https://orcid.org/0000-0001-6475-7801)
- Arina Šablinskaja (ORCID: https://orcid.org/0000-0003-4641-2695)
- Kristi Rüütel (ORCID: https://orcid.org/0000-0001-7999-9619)
- Kristi Huik (ORCID: https://orcid.org/0000-0002-1569-8830)
- Taavi Päll (ORCID: https://orcid.org/0000-0001-7606-675X)
- Heli Rajasaar
- Ene‐Ly Jõgeda
- Kati Hensen
- Pilleriin Soodla (ORCID: https://orcid.org/0000-0003-1445-7653)
- Radko Avi (ORCID: https://orcid.org/0000-0002-9640-8427)
- Jekaterina Tabri
- Eveli Kallas (ORCID: https://orcid.org/0000-0003-3735-928X)
- Merit Pauskar
Institutions
- Tartu University Hospital (EE)
- East Tallinn Central Hospital (EE)
- National Institute for Health Development (EE)
- University of Tartu (EE)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.jgar.2025.01.008
- Citations
- 2
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Eesti Teadusagentuur